Nanosonics Limited Just Reported Profit Down 90%

Ultrasound probe disinfection company Nanosonics Limited (ASX: NAN) released its half year financial report to investors on Friday, showing a 90% decrease in profit.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

Ultrasound probe disinfection company Nanosonics Limited (ASX: NAN) released its half year financial report to investors on Friday, showing a 90% decrease in profit.

Nanosonics describes itself as setting a new standard in ultrasound probe disinfection around the world with its trophon device.

Here are some of the highlights compared to last year:

  • Sales down 17% to $30 million
  • Gross profit down 15% to $22.3 million
  • Operating income before tax down 64% to $3.7 million
  • Profit down 90% to $2.2 million

Nanosonics CEO Michael Kavanagh said “In North America the strong adoption of trophon was maintained with a further 1,700 new units adopted in the half, growing the overall North American installed base to approximately 14,100 units.”

The company said that the reduction in sales was expected, mainly due to the GE Healthcare reduction of $1.8 million.

The company had an income tax benefit last year of $11.7 million, whereas this year it was a $1.5 million cost to Nanosonics.

Nanosonics increased its UK sales and service team as well as appointing a regional manager for Europe and the Middle East region. This is hoped to support the long-term growth strategy.

In the UK it increased its managed equipment service ‘MES’ installed base units by 86% in the half. MES is where the equipment is placed in hospitals for a contracted period and the facility pays for an all-inclusive price for consumables in return for the use and maintenance of the capital equipment.

The company said that the fundamentals for adoption across Europe also strengthened with the release of a number of new regulations including guidelines from the British Medical Ultrasound Society as well as the European Society of Radiology.

Mr Kavanagh said that in the second half of FY18 the company expects continued growth in North America similar to the first half and new unit growth in the UK of 75% to 100%.

Beyond FY18 Nanosonics expects strong growth of trophon in all installed core markets, expansion into new markets, a new GE Healthcare agreement and the introduction of new products including the second generation of trophon.

The Nanosonics share price has fallen 12.3% according to Google Finance.

Join Rask’s Investor Club Newsletter Today

You can join Rask’s FREE investor’s club newsletter today for all of the latest news and education on investing. Join today – it doesn’t cost a thing. BUT

, you’ll need a good sense of humour and a willingness to learn.

Join today.

Keep Reading

 

Disclaimer: This article contains general information only. It is no substitute for licensed financial advice and should not be relied upon. By using our website you agree to our Disclaimer & Terms of Use and Privacy Policy

Live webinar (with Q&A)

Earnings Season Whiplash
Why prices jump and crash, and how to think clearly when results hit

  • Presented by Owen Rask & Leigh Gant
  • Monday, 16 February   | 7pm AEDT 

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.